Evaluation of the Analgesic Effects of Prolonged-release Oxycodone and of Levodopa, Versus Placebo, on Central Neuropathic Pain in Parkinson's Disease: OXYDOPA Trial

Trial Profile

Evaluation of the Analgesic Effects of Prolonged-release Oxycodone and of Levodopa, Versus Placebo, on Central Neuropathic Pain in Parkinson's Disease: OXYDOPA Trial

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 17 Jul 2017

At a glance

  • Drugs Oxycodone (Primary) ; Levodopa
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Acronyms OXYDOPA
  • Most Recent Events

    • 11 Jul 2017 Status changed from not yet recruiting to recruiting.
    • 13 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top